# Entecavir

## Baraclude 0.5mg

##### 

| 藥品代碼   | OBAR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Treatment of chronic HBV infection in adults with evidence of active viral replication & either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 用法用量   | Administer on an empty stomach (2 hours before or after a meal). Adults and adolescents > 16 years: nucleoside-treatment naive， compensated liver disease: 0.5 mg once daily; decompensated liver disease: 1 mg once daily. Children and adolescents 2 to <16 years: 10 to 11 kg: 0.15 mg oral solution once daily >11 to 14 kg: 0.2 mg oral solution once daily >14 to 17 kg: 0.25 mg oral solution once daily >17 to 20 kg: 0.3 mg oral solution once daily >20 to 23 kg: 0.35 mg oral solution once daily >23 to 26 kg: 0.4 mg oral solution once daily >26 to 30 kg: 0.45 mg oral solution once daily >30 kg: 0.5 mg oral solution or tablet once daily |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 禁忌       | Patients who previously demonstrated hypersensitivity to entecavir or any of the components of Baraclude.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 副作用     | Diarrhea， dyspepsia， nausea， vomiting. Fatigue. Headache， dizziness， somnolence. Insomnia. Gastrointestinal: Nausea (all grades， 3% or greater; grade 2 to 4， less than 1% ) Neurologic: Dizziness (all grades， 3% or greater; grade 2 to 4， less than 1% )， Headache (all grades， 3% or greater; grade 2 to 4， 2% to 4% ) Other: Fatigue (all grades， 3% or greater; grade 2 to 4， 1% to 3% )                                                                                                                                                                                                                                                 |
| 孕期建議   | Compatible – maternal benefit >> embryo-fetal risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

## 1mg BARACLUDE

##### 

| 藥品代碼   | OBAR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Treatment of chronic hepatitis B virus (HBV) infection in adults and pediatric patients 2 years and older with evidence of active viral replication and either evidence of persistent transaminase elevations or histologically-active disease. Note: In adults， indication is based on data in patients with compensated and decompensated liver disease; in children， indication is based on data in patients with compensated liver disease.                                                                                                                                                                                                            |
| 用法用量   | Administer on an empty stomach (2 hours before or after a meal). Adults and adolescents > 16 years: nucleoside-treatment naive， compensated liver disease: 0.5 mg once daily; decompensated liver disease: 1 mg once daily. Children and adolescents 2 to <16 years: 10 to 11 kg: 0.15 mg oral solution once daily >11 to 14 kg: 0.2 mg oral solution once daily >14 to 17 kg: 0.25 mg oral solution once daily >17 to 20 kg: 0.3 mg oral solution once daily >20 to 23 kg: 0.35 mg oral solution once daily >23 to 26 kg: 0.4 mg oral solution once daily >26 to 30 kg: 0.45 mg oral solution once daily >30 kg: 0.5 mg oral solution or tablet once daily |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 禁忌       | Hypersensitivity to entecavir or any component of the formulation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 副作用     | Diarrhea， dyspepsia， nausea， vomiting. Fatigue. Headache， dizziness， somnolence. Insomnia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 孕期建議   | Compatible – maternal benefit >> embryo-fetal risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

